AVENUE SOLUTIONS for GENENTECH USA, INC.
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to Medicare Part B, CMS coverage and reimbursement, 340b drug pricing program; Continued monitoring of Prescription Drug Pricing Reduction Act of 2019 from 116th Congress; Continued monitoring of Elijah E. Cummings Lower Drug Costs Now Act from 116th Congress; Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; H.R. 5376, Build Back Better Act; S.773, A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes; Issues related to the confluence of flu and COVID; S.3799, PREVENT Pandemics Act; S. 3700/H.R. 6833, Affordable Insulin Now Act; Issues related to the Senate Finance report on mental health and mental health legislation; Senate Finance Committee bipartisan Discussion Draft: Ensuring Access to Telemental Health Services; Senate Finance Committee bipartisan Discussion Draft: Improving Access to Physical and Mental Health Care for Children and Youth under Medicaid and CHIP; Bipartisan Safer Communities Act, P.L. 117-159, specifically policy related to access to mental health services for youth and families through Medicaid and CHIP and telehealth; H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022; Issues related to reauthorization of FDA user fee bills (H.R.7667, Food and Drug Amendments of 2022; S.4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; Issues related to accelerated approval; Issues related to patient assistance programs and copay accumulators; Issues related to the FY 2023 Presidents Budget; Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH MACDONALD BARNETT | — |
| TRACY SPICER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.